CymitQuimica logo

CAS 909561-15-5

:

1-Piperazineacetamide, 4-[4-[[7-[(3,5-difluorophenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]phenyl]-

Description:
1-Piperazineacetamide, 4-[4-[[7-[(3,5-difluorophenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]phenyl]- is a chemical compound characterized by its complex structure, which includes a piperazine ring and a pyrrolopyrimidine moiety. This compound is typically classified as a small molecule and may exhibit properties relevant to medicinal chemistry, particularly in the context of drug development. The presence of fluorine atoms in the difluorophenyl group can influence its pharmacokinetic properties, such as lipophilicity and metabolic stability. The piperazine and acetamide functionalities may contribute to its biological activity, potentially interacting with various biological targets. The compound's CAS number, 909561-15-5, allows for precise identification in chemical databases. Overall, this substance may be of interest in research related to therapeutic applications, particularly in areas such as oncology or neurology, where pyrimidine derivatives are often explored for their potential efficacy.
Formula:C25H25F2N7O
Synonyms:
  • 1-Piperazineacetamide, 4-[4-[[7-[(3,5-difluorophenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]phenyl]-
  • AS1810722
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
  • AS1810722
    Apollo Scientific
    + Info

    AS1810722

    CAS:
    AS1810722
    Purity:≥98%
    Molecular weight:477.51g/mol

    Ref: 54-BUP01142

    1mg
    162.00€
    5mg
    341.00€
    10mg
    504.00€
    25mg
    826.00€
  • AS1810722
    Targetmol
    + Info

    AS1810722

    CAS:
    AS1810722, a fused bicyclic pyrimidine derivative, is an orally active and potent inhibitor of STAT6, demonstrating an IC50 of 1.9 nM.
    Formula:C25H25F2N7O
    Purity:99.13%
    Color and Shape:Solid
    Molecular weight:477.51

    Ref: TM-T9043

  • aS1810722
    Biosynth
    + Info

    aS1810722

    CAS:
    aS1810722 is a potent inhibitor of kinases that has shown promise in the treatment of cancer. This protein analog is derived from human urine and has been found to inhibit the activity of ghrelin, which is known to promote tumor growth. In preclinical studies, aS1810722 has demonstrated strong anticancer activity by inducing apoptosis in cancer cells and inhibiting tumor growth. This inhibitor has been tested on Chinese hamster ovary cells and has shown promising results as a potential therapeutic agent for the treatment of various cancers. Its specificity for kinases makes it an attractive candidate for targeted cancer therapy.
    Formula:C25H25F2N7O
    Purity:Min. 95%
    Molecular weight:477.5 g/mol

    Ref: 3D-JLB56115

    25mg
    1,032.00€
    50mg
    1,354.00€